The Ministry of Health is ramping up efforts to tackle the Mpox outbreak and address the potential risk of Marburg Virus Disease (MVD).
Since the initial cases of Mpox were reported in July 2024, 36 confirmed cases have been recorded, with the highest numbers in Nakuru, Mombasa, and Busia.
Groups targeted for Mpox vaccination in Kenya
At a Media Sensitization Meeting held on January 23, 2025, Principal Secretary for Public Health and Professional Standards Mary Muthoni Muriuki announced the launch of a targeted vaccination campaign aimed at high-risk groups, including healthcare workers and individuals who have had close contact with confirmed cases.
Public awareness campaigns are also being launched to counter misinformation and provide the public with accurate information.
PS Muthoni also emphasized the importance of collaboration to reduce vaccine hesitancy.
“Accurate, reliable information about the Mpox vaccine must reach all communities, particularly those most at risk,” she said.
In addition, the Ministry is enhancing surveillance, distributing personal protective equipment (PPE), and providing training for healthcare workers to improve the response and management of the virus.
How Kenya is addressing Marburg threat
In light of the Marburg threat posed by the outbreak in Tanzania’s Kagera region, Kenya has heightened surveillance at border points.
“While we remain vigilant in the fight against Mpox, we are also prepared for the possibility of a Marburg outbreak,” PS Muthoni added.
Furthermore, the Ministry is working closely with international health organizations, such as the World Health Organization (WHO), UNICEF, and the U.S. Centers for Disease Control and Prevention (CDC), to ensure a swift and coordinated response to both Mpox and Marburg.
The PS also reaffirmed the Ministry’s commitment to strengthening health systems and ensuring the country is well-prepared for emerging health risks.
